MISSISSAUGA, Ontario The merger between Valeant Pharmaceuticals International and Biovail is complete, the two companies said Tuesday.

Shareholders of both companies have approved the merger, worth more than $3 billion, originally announced in June.

The combined company will take Valeant’s name.